Research programme: coronavirus inhibitors - Fulcrum/Johns Hopkins University
Alternative Names: 3CLpro inhibitors; Coronavirus inhibitors research programme - Fulcrum/Johns Hopkins University; Coronavirus protease inhibitorsLatest Information Update: 13 Nov 2003
Price :
$50 *
At a glance
- Originator Fulcrum Pharmaceuticals; Johns Hopkins University
- Class
- Mechanism of Action Peptide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Coronavirus infections
Most Recent Events
- 13 Nov 2003 Preclinical trials in Coronavirus infections in USA (unspecified route)